SCHEMBL3479952

SCHEMBL3479952

CN1CCN(c2ccc3c(c2)CN(C)CCN3c2ccc(Cl)cc2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.50
MAPT P10636 4/20 0.48
GAA P10253 4/20 0.48
KDM4E B2RXH2 3/20 0.48
PTK2B Q14289 2/20 0.48
MAPK1 P28482 1/20 0.48
HTT P42858 1/20 0.48
RECQL P46063 1/20 0.48
TMEM97 Q5BJF2 3/20 0.45
SIGMAR1 Q99720 3/20 0.45
RAD52 P43351 1/20 0.43
ADRA2C P18825 2/20 0.43
ALDH1A1 P00352 2/20 0.42
KMT2A Q03164 2/20 0.42
GFER P55789 1/20 0.42
ESR2 Q92731 1/20 0.42
HTR3A P46098 2/20 0.42
HTR2C P28335 1/20 0.42
ALOX12 P18054 1/20 0.42
HTR6 P50406 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3479556 0.91 ADRB1 (0.51) POLBHTTSIGMAR1HTR3AHTR2C
SCHEMBL3224415 0.91 SLC6A2 (0.46) POLBMAPTGAAKDM4EPTK2B
SCHEMBL3239224 0.89 RORC (0.48) POLBTMEM97SIGMAR1ALDH1A1KMT2A
SCHEMBL3233345 0.88 SLC6A2 (0.53) POLBGAATMEM97SIGMAR1ALDH1A1
SCHEMBL3479777 0.87 ADRA2C (0.51) MAPTGAAKDM4EPTK2BMAPK1
SCHEMBL3480071 0.86 MAPT (0.50) POLBMAPTGAAKDM4EPTK2B
SCHEMBL3479640 0.86 ALDH1A1 (0.50) MAPTGAAKDM4EPTK2BMAPK1
SCHEMBL3223749 0.84 POLB (0.42) POLBMAPTGAAKDM4EPTK2B
SCHEMBL3218294 0.84 ALDH1A1 (0.46) POLBMAPTKDM4ERAD52ALDH1A1
SCHEMBL3479739 0.83 GAA (0.46) POLBMAPTGAAKDM4EPTK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US disclosed
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ADRA1B, ADRB1, ADRA1D POLB 2863/4885MAPT 2307/4885GAA 3775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.